Completed PHASE1 INTERVENTIONAL 3-arm NCT04639804

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

An Open-label, Randomized, Crossover Study to Evaluate the Pharmacokinetic Interaction Between Tegoprazan and Non-steroidal Anti-inflammatory Drugs (NSAIDs) After Multiple Oral Dosing in Healthy Male Volunteers

Sponsor: HK inno.N Corporation

Conditions Healthy

Interventions Aceclofenac Celecoxib Naproxen Tegoprazan

Updated 5 times since 2020 Last updated: Nov 20, 2020 Started: Jun 6, 2020 Primary completion: Jul 26, 2020 Completion: Jul 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by HK inno.N Corporation and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Dec 2020 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HK inno.N Corporation

Data source: HK inno.N Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeonju, South Korea